Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement
May 02, 2024 08:00 ET
|
Mangoceuticals, Inc.
Dallas, Texas, May 02, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...
MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment
March 12, 2024 09:00 ET
|
Mangoceuticals, Inc.
The Dallas Based, Direct-to-Consumer Telemedicine Company Brings the FDA-Approved Oral Testosterone Replacement Therapy Treatment to the Telehealth Market Dallas, Texas, March 12, 2024 (GLOBE...
Global Erectile Dysfunction Treatment Market Insights Report 2024: ED Market was Valued at $4.727 Billion in 2023, Registering a Negative CAGR of -0.94% - Forecasts to 2029
February 09, 2024 08:33 ET
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Erectile Dysfunction Treatment Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The global...
MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS
February 06, 2024 09:00 ET
|
Mangoceuticals, Inc.
MangoRx Wants to Keep Fumbles on the Field, Not in the Bedroom, Offering the Losing Team Free MangoRx ED Products for One Year Dallas, Texas, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals,...
MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11
January 19, 2024 08:00 ET
|
Mangoceuticals, Inc.
"King of the Internet" Dave Portnoy's Uber-Popular Sports Media Company to Spotlight FDA-Approved Oral Testosterone Replacement ‘Prime’ by MangoRx, Powered by Kyzatrex® Dallas, Texas, Jan. 19,...
Global Erectile Dysfunction Drugs Market Research Report 2023 and 2024-2034: Regulatory Approvals Boost Market Prospects, Viagra Dominates, Research and Development Activities Surge
January 15, 2024 10:18 ET
|
Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Global Erectile Dysfunction Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The...
Shock Wave Therapy Devices Market Size to Exceed USD 158.5 million by 2031, with a Robust CAGR of 5.2 %| States Transparency Market Research, Inc.
December 14, 2023 08:45 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global shock wave therapy devices market was projected to attain US$ 101.3 million in...
Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America
December 06, 2023 08:00 ET
|
Mangoceuticals, Inc.
Tapping into a market of more than 40,000 pharmacies, retail outlets, and convenience stores across Mexico in 2024 and fueling International Sales Access Across Latin America Dallas, Texas,...
Mangoceuticals, Inc. Launches Charitable Initiative in Support of Men’s Health Awareness Month
November 02, 2023 09:15 ET
|
Mangoceuticals, Inc.
Dallas, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...
Global Drugs for Erectile Dysfunction Market 2023-2027: Insights & Projections for Sildenafil, Mirodenafil, and Vardenafil
July 27, 2023 05:18 ET
|
Research and Markets
Dublin, July 27, 2023 (GLOBE NEWSWIRE) -- The "Drugs For Erectile Dysfunction Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global drugs for erectile...